Stan Polovets | |
---|---|
Станислав Половец[1] | |
Born | Moscow, Soviet Union (present-day Russia) | June 8, 1963
Nationality | American |
Occupation(s) | Businessman and philanthropist |
Organizations | L1 Energy/Alfa Group, Genesis Prize Foundation, Access Industries, Edelman, Stanford University, New York University |
Stan Polovets (born June 8, 1963) is an American businessman and philanthropist. He is known for his work in the international energy sector and for his innovative philanthropic initiatives.[2]
Polovets played a notable role in the creation of TNK-BP, one of the largest joint ventures in the global energy industry, which operated in 2003-2013 and controlled more than 18% of Russia’s total oil production. He held a number of executive and board posts and was instrumental in its subsequent divestment in a record $55 billion transaction.[3]
In May 2020, Polovets was elected chairman of the board of directors of Anchiano Therapeutics Ltd.,[4][5] a NASDAQ-listed biopharmaceutical company. In March 2021, he stepped down as chairman after the company posted a 630% return in 12 months, and merged with Israel-based Chemomab Therapeutics.[6]
Polovets is a member of the Council on Foreign Relations, the President’s Global Council at New York University (NYU), and the Board of Overseers at the NYU Tandon School of Engineering.[7] From 2014 to 2019, he served on the Board of Overseers of Stanford University's Hoover Institution.[8][9]
He is the co-founder and chairman/CEO of the Genesis Prize Foundation, a global philanthropic initiative focused on enhancing Jewish identity.[10][11]